An International Examination of Serotonin Reuptake Inhibitors

Samuel Dans^*
*Correspondence: Samuel Dans, Department of Psychology, Health Psychology Center, Houston, USA, Email:

Introduction

Developing a computational tool to forecast the acute toxicity of biocidal active chemicals and its environmental degradation products for aquatic species is one of the objectives of the European project LIFE-COMBASE. Data on these compounds' toxicity to species in the freshwater/marine and sewage treatment plant compartments have been included in a database. In order to determine whether these substances could be hazardous to aquatic compartments, this study will assess the data that has been gathered. We looked up a number of governmental and scholarly databases. The taxonomic categories, including fish, invertebrates, algae, and Sewage Treatment Plant (STP) microorganisms, were studied using data from 196 biocidal chemicals and 206 environmental metabolites.

Concerns about potential negative effects in aquatic species and threats to public health when antibiotics impact the development of resistant microbes have grown as a result of the presence of pharmaceutical substances in the environment. These worries have grown as a result of unprecedented urbanisation and population expansion around the world, particularly in megacities in developing countries [1].

The US Federal Food, Drug and Cosmetic Act (US FD&C Act, 1958) first suggested a TTC-like approach for chemicals in food contact material (and their components) in the US, along with the development of more sensitive and discriminating analytical methods to handle potential toxicological risks of low exposures. In order to reduce lengthy toxicity studies and safety evaluations and to address, within the capacity available, those substances for which the potential or actual intake is substantial, first presented an analysis to establish a generic threshold value (threshold of regulation; ToR) or ranges values [2].

Description

The type of technology employed at each distinct facility was indicated in papers where particular wastewater treatment plants were researched and information was available. The five categories—primary, secondary, disinfection procedures, filtration processes, and advanced wastewater treatment processes—were used to classify various wastewater treatment techniques. Tertiary treatment processes often relate to the utilisation of treatment technologies in addition to conventional secondary treatment. Filtration and other sophisticated techniques are available as tertiary therapy alternatives. Processes known as filtration involve the passage of wastewater through artificial filters like membranes or more sophisticated filters like sand. In addition to lowering suspended particles and other organic waste in effluent, these methods can eliminate germs and viruses [3].

Since the acute impacts are given priority in the Biocidal Product Regulation, the acute danger has received attention (BPR). These data are necessary for the "core data set," but information about long-term impacts is only necessary for the extra data set and is therefore called "complementary." This is not to say that long-term impacts are not significant. In actuality, the Technical Guidance Document on Risk Assessment (European Commission, 2003) is used to set the Predicted No Effect Concentration (PNEC) for a certain environmental compartment. This document addresses both acute and chronic toxicity. Depending on the taxonomic groups and studies of acute or chronic toxicity that are available, different assessment variables are used in the context of the PNEC [4,5].

Conclusion

The majority of the peer-reviewed, published articles on the presence of SSRIs in various aquatic matrices throughout the course of the past 18 years have been released since 2010. Only two researches came from South Africa, while the majority of articles came from Europe (77), North America (58), and Asia-Pacific (15). Some regions of Europe, the Middle East, and portions of Asia-Pacific had little or no data on occurrence (e.g., Japan, Vietnam, and South Korea). Additionally, there were few to no research from the major continents, such as Africa (and Antarctica).

References

1. Antosik-Wójcińska, Anna, Bogdan Stefanowski and Łukasz Święcicki. "Efficacy and safety of antidepressant’s use in the treatment of depressive episodes in bipolar disorder–review of research." Psychiatr Pol 49 (2015): 1223-1239.

Google Scholar, Indexed at

2. Xue, Weiwei, Panpan Wang, Bo Li and Yinghong Li, et al. "Identification of the inhibitory mechanism of FDA approved selective serotonin reuptake inhibitors: An insight from molecular dynamics simulation study." Phys Chem Chem Phys 18 (2016): 3260-3271.

Google Scholar, Crossref, Indexed at

3. Kocsis, James H. "SSRIs and TCAs equally effective at treating chronic depression and dysthemia; SSRIs are associated with fewer adverse events than TCAs." EBMH 16 (2013): 82-82.

Google Scholar, Crossref, Indexed at

4. Laporte, Silvy, Céline Chapelle, Pascal Caillet and Marie-Noëlle Beyens, et al. "Bleeding risk under selective serotonin reuptake inhibitor (SSRI) antidepressants: A meta-analysis of observational studies." Pharm Res 118 (2017): 19-32.

Google Scholar, Crossref, Indexed at

5. Horowitz, B. Zane and Michael E. Mullins. "Cyproheptadine for serotonin syndrome in an accidental pediatric sertraline ingestion." Pediatr Emerg Care 15 (1999): 325-327.

Google Scholar, Crossref, Indexed at